QTHCPX Mutual Fund

QTHCPX Mutual Fund

See how much of QTHCPX you already own
Just $25 once·$99/mo·Download sample
X-ray my portfolio free

Fund Essentials - as of Jul 31, 2026

Net Assets
-
Expense Ratio
0.92%
Dividend Yield (Current)
-
Holdings
45
Inception Date
Apr 30, 2008
Fund Family
Thrivent Funds
Investment Style
PRO
Asset Class
PRO
Legal Structure
PRO

Performance

1 Year+25.42%
3 Year+6.87%
5 Year+3.85%
10 Year+8.22%

Asset Allocation

Stocks: 98.75%
Cash: 0.56%
Other: 0.68%
See how much of QTHCPX you already own
Your funds unpacked, overlap, fees and score, free on screen. The full report comes with FundXLS. Download sample.
X-ray my portfolio free

Top Holdings

View All →
TickerNameWeight
LLYEli Lilly & Co.14.86%
JNJJohnson & Johnson - Common8.98%
UNHUnitedhealth Group Incorporated6.60%
ABBVAbbvie Inc.6.47%
MRKMerck & Company Inc4.19%
Top 10 Concentration: 56.49%Report Date: Jul 31, 2026
Download all 45 holdings for QTHCPX
CSV export with sector, industry & share changes
Get CSV

Peer Comparison

Benchmark
PRO
Peer outperformance: PRO
Category rank: PRO
This Mutual Fund
PRO
Peer Avg
PRO

QTHCPX Mutual Fund Overview

QTHCPX Mutual Fund (Thrivent Healthcare Portfolio) is managed by Thrivent Funds. QTHCPX expense ratio is 0.92%, holding 45 positions across sectors including Health Care, Financials. Inception date: 2008-04-30.

QTHCPX performance shows data across multiple time periods. The 1-year return is 25.42% and the 5-year return is 3.85%.

QTHCPX top holdings include Eli Lilly & Co. (14.9%), Johnson & Johnson - Common (9.0%), Unitedhealth Group Incorporated (6.6%), Abbvie Inc. (6.5%), Merck & Company Inc (4.2%). Go to all QTHCPX holdings, QTHCPX sectors, or QTHCPX dividends.

QTHCPX can be compared against other funds. Use QTHCPX overlap to find shared positions, or QTHCPX vs another fund for a side-by-side view. QTHCPX alternatives are available via the screener, along with tax-loss harvesting opportunities.